Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Minkyu Heo
Observed name:
MinKyu Heo
Observed institution:
Genexine (South Korea)
ORCID:
0009-0007-2041-8104
Observed ORCID:
0009-0007-2041-8104
OpenAlex ID:
A5019223339
hIL‐7‐hyFc, A Long‐Acting IL‐7, Increased Absolute Lymphocyte Count in Healthy Subjects
2020
·
Sang Won Lee
, Donghoon Choi
, et al.
·
Clinical and Translational Science
·
50
PDF
Compassionate use of recombinant human IL‐7‐hyFc as a salvage treatment for restoring lymphopenia in patients with recurrent glioblastoma
2022
·
Stephen Ahn
, Jae‐Sung Park
, et al.
·
Cancer Medicine
·
21
PDF
A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained effector functions
2022
·
Sojeong Kim
, Sang Won Lee
, et al.
·
Blood Advances
·
19
PDF
Long-acting FC-fusion rhGH (GX-H9) shows potential for up to twice-monthly administration in GH-deficient adults
2018
·
Cheol Ryong Ku
, Thierry Brue
, et al.
·
European Journal of Endocrinology
·
18
PDF
Phase 1 Study of Immunotherapy Using Autoantigen-Loaded Dendritic Cells in Patients with Anti-Citrullinated Peptide Antigen Positive Rheumatoid Arthritis
2014
·
Young Bin Joo
, Jun‐Eui Park
, et al.
·
10
Preliminary safety and efficacy of GX-I7, a long-acting interleukin-7, in combination with pembrolizumab in patients with refractory or recurrent metastatic triple negative breast cancer (mTNBC): Dose escalation period of Phase Ib/II study (KEYNOTE-899).
2020
·
Joohyuk Sohn
, Kyong Hwa Park
, et al.
·
Journal of Clinical Oncology
·
3
SAT-LB15 24-Month Efficacy and Safety of Once Weekly and Every Other Week Administration of GX-H9, Hybrid FC-Fused Long-Acting Human Growth Hormone: A Phase 2 Study in Children With Growth Hormone Deficiency
2020
·
Oleg Malievskiy
, Aryaev Mykola
, et al.
·
Journal of the Endocrine Society
·
3
PDF
Phase 1b/2 study of GX-I7 plus pembrolizumab in patients with refractory or recurrent (R/R) metastatic triple-negative breast cancer (mTNBC): The KEYNOTE-899 Study.
2022
·
Joohyuk Sohn
, Gun Min Kim
, et al.
·
Journal of Clinical Oncology
·
2
Vactosertib plus pembrolizumab in patients with non-microsatellite instability-high metastatic colorectal or gastric cancer: a multicenter, phase Ib/IIa study
2026
·
Keun-Wook Lee
, Young Suk Park
, et al.
·
Nature Communications
·
1
PDF
GX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin’s lymphoma.
2019
·
Senem Ertan-Ahmed
, Michael G. Kiehl
, et al.
·
Journal of Clinical Oncology
·
1
A Single Administration of Fc-Fused Recombinant Human IL-7 Induces Expansions of T Lymphocytes in Healthy Adult Volunteers
2019
·
Sojeong Kim
, Dong-Hoon Choi
, et al.
·
The Journal of Immunology
·
1
1311 Targeting TGF-β RI signaling with the novel vactosertib: preliminary antitumor activity in a phase 1 study in patients with recurrent, refractory, and progressive osteosarcoma
2025
·
Jun Ah Lee
, Kristen VanHeyst
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
A single administration of Fc-fused recombinant human IL-7 induces expansions of T lymphocytes in healthy adults and cancer patients
2020
·
Sojeong Kim
, Minkyu Heo
, et al.
·
The Journal of Immunology
Abstract CT045: Hyleukin-7, a long-acting interleukin-7, increased absolute lymphocyte counts after subcutaneous and intramuscular administration in healthy subjects
2019
·
Sang Won Lee
, Donghoon Choi
, et al.
·
Clinical Trials
Abstract CT045: Hyleukin-7, a long-acting interleukin-7, increased absolute lymphocyte counts after subcutaneous and intramuscular administration in healthy subjects
2019
·
Sang Won Lee
, Donghoon Choi
, et al.
·
Cancer Research
Show more works
View as search
Works count:
15
Citation count:
129
H-index:
5
I10-index:
5
Year
Topic
Type
